FMI - Foundation Medicine, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Foundation Medicine, Inc.

150 Second Street
Cambridge, MA 02141
United States

IndustryMedical Laboratories & Research
Full Time Employees662

Key Executives

NameTitlePayExercisedYear Born
Mr. Alexis BorisyCo-Founder, Founding Advisor & Independent Director114kN/A1972
Mr. Troy CoxCEO, Pres & DirectorN/AN/A1964
Mr. Jason RyanCFO & Principal Accounting OfficerN/AN/A1974
Mr. Konstantin FiedlerChief Operating OfficerN/AN/A1966
Mr. Tom GoddenChief Information OfficerN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Foundation Medicine, Inc. provides various molecular information products in the United States. The company's molecular information platform includes proprietary methods and algorithms to analyze specimens across various types of cancer, as well as for incorporating that information into clinical care; and offers genomic insights about each patient's individual cancer, enabling physicians to optimize treatments in clinical practice and biopharmaceutical companies to develop targeted therapies and immunotherapies. It provides clinical products, such as FoundationOne for solid tumors; FoundationOne Heme for blood-based cancers, or hematologic malignancies, including leukemia, lymphoma, and sarcomas; Foundation Assay for Circulating Tumor; FoundationFocus CDxBRCA, a diagnostic assay to aid in identifying women with ovarian cancer; and FoundationOne CDx, a diagnostic assay for solid tumors. The company also offers FoundationCORE, a knowledgebase to publish scientific and medical advances, and foster relationships throughout the oncology community. In addition, it has strategic collaboration agreements with F. Hoffmann-La Roche Ltd.; and Genentech, Inc. Foundation Medicine, Inc. has a collaboration with The European Organisation for Research and Treatment of Cancer to advance precision medicine using comprehensive genomic profiling to facilitate clinical trial enrollment. The company was founded in 2009 and is headquartered in Cambridge, Massachusetts. Foundation Medicine, Inc. is a subsidiary of Roche Holdings, Inc.

Corporate Governance

Foundation Medicine, Inc.’s ISS Governance QualityScore as of March 1, 2018 is 9. The pillar scores are Audit: 1; Board: 10; Shareholder Rights: 5; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.